Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus

NeuroImmunoModulation

Volumn 19, Issue 4, 2012, Pages 241-254

  Shukla, Vibha ^a   Kumar Shakya, Akhalesh ^a   Dhole, T N ^a   Misra, Usha Kant ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Brain tissue; Japanese encephalitis virus; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL; UPREGULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; BRAIN; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 84858989822     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000335182     Document Type: Article

References (69)

1. Chen CJ, Raung SL, Kuo MD, Wang YM: Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J Gen Virol 2002;83:1897-1905.
2. World Health Organization: Manual for the laboratory diagnosis of japanese encephalitis virus infection. Geneva, WHO, 2007.
3. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT: Japanese encephalitis. J Neurol, Neurosurg, Psychiatry 2000;68:405-415. (Pubitemid 30248738)
4. King NJ, Shrestha B, Kesson AM: Immune modulation by flaviviruses. Adv Virus Res 2003;60:121-155. (Pubitemid 137639375)
5. Mathur A, Arora KL, Chaturvedi UC: Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 1983;64:805-811. (Pubitemid 13163218)
6. Desai A, Ravi V, Chandramuki A, Gourie-Devi M: Detection of neutralizing antibodies to Japanese encephalitis virus in the cerebrospinal fluid using a rapid microneutralization test. Serodiagn Immunother Infect Dis 1994;6:130-134. (Pubitemid 24287575)
7. Murali-Krishna K, Ravi V, Manjunath R: Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J Gen Virol 1996;77:705-714.
8. Ramakrishna C, Ravi V, Desai A, Subbakrishna DK, Shankar SK, Chandramuki A: T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used. J Gen Virol 2003;84:1559-1567. (Pubitemid 36675527)
9. Kumar P, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V: Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. J Gen Virol 2004;85:1131-1143. (Pubitemid 38659777)
10. Parks WC, Wilson CL, López-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-629. (Pubitemid 39025047)
11. Kieseier BC, Paul R, Koedel U, Seifert T, Clements JM, Gearing AJ, Pfister HW, Hartung HP: Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 1999;122:1579-1587. (Pubitemid 29374132)
12. Perry VH, Anthony DC, Bolton SJ, Brown HC: The blood-brain barrier and the inflammatory response. Mol Med Today 1997;3:335-341. (Pubitemid 28119268)
13. Ransohoff RM, Kivisäkk P, Kidd G: Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003;3:569-581. (Pubitemid 37328676)
14. Yong VW, Power C, Forsyth P, Edwards DR: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001;2:502-511. (Pubitemid 33676585)
15. Nygårdas PT, Hinkkanen AE: Up regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin Exp Immunol 2002;128:245-254. (Pubitemid 34534037)
16. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL: Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998;152:729-741. (Pubitemid 28110720)
17. Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF: Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog Neurobiol 1996;49:169-184. (Pubitemid 26253267)
18. Giraudon P, Vernant JC, Confavreux C, Belin MF, Desgranges C: Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology 1998;50:1920. (Pubitemid 28283290)
19. Lezin A, Buart S, Smadja D, Akaoka H, Bourdonne O, Perret-Liaudet A, Cesaire R, Belin MF, Giraudon P: Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers. AIDS Res Hum Retroviruses 2000;16:965-972. (Pubitemid 30436495)
20. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN: Cerebrospinal fluid levels of MMP-2, -7, and -9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 1999;46:391-398. (Pubitemid 29416277)
21. Kolb SA, Lahrtz F, Paul R, Leppert D, Nadal D, Pfister HW, Fontana A: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol 1998;84:143-150. (Pubitemid 28248399)
22. Khuth ST, Akaoka H, Pagenstecher A, Verlaeten O, Belin MF, Giraudon P, Bernard A: Morbillivirus infection of the mouse central nervous system induces region-specific up-regulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 2001;75:8268-8282. (Pubitemid 32743699)
23. Zhou J, Marten NW, Bergmann CC, Macklin WB, Hinton DR, Stohlman SA: Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 2005;79:4764-4773. (Pubitemid 40464227)
24. Suzuki T, Ogata A, Tashiro K, Nagashima K, Tamura M, Yasui K, Nishihira J: Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain. Biochim Biophys Acta 2000;1517:100-106.
25. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ: Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-268.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
27. Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH, Cho CS: Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 2005;7:R71-R79.
28. Huang CH, Wong C: Relation of the peripheral multiplication of Japanese B encephalitis virus to the pathogenesis of the infection in the mice. Acta Virol 1963;7:322-330.
29. Mac Donald F: Murrey valley encephalitis infection in the laboratory mouse. 1. Influence of age on the susceptibility of infection. Aust J Exp Biol Med Sci 1952;30:319-324.
30. Martínez-Torres FJ, Wagner S, Haas J, Kehm R, Sellner J, Hacke W, Meyding-Lamadé U: Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis. Neurosci Lett 2004;368:274-278.
31. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C: HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003;6:1064-1071. (Pubitemid 37186198)
32. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM: Matrix metalloproteinase activity inactivates the cxc chemokine stromal cell-derived factor-1. J Biol Chem 2001;276:43503-43508.
33. Dean RA: Overall cm proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics 2007;6:611-623.
34. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G: Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO- and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681.
35. Van den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G: Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 2003;270:3739-3749. (Pubitemid 37123245)
36. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM: Inflammation dampened by gelatinase a cleavage of monocyte chemoattractant protein-3. Science 2000;289:1202-1206.
37. Agrawal S, Anderson P, Durbeej M, Van Rooijen N, Ivars F, Opdenakker G, Sorokin LM: Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. Journal Exp Med 2006;203:1007-1019.
38. Hu J, Van den Steen PE, Sang QX, Opdenakker G: Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 2007;6:480-498. (Pubitemid 47064570)
39. Harris JE, Fernandez-Vilaseca M, Elkington PT, Horncastle DE, Graeber MB, Friedland JS: IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis. FASEB J 2007;21:356-365. (Pubitemid 46213483)
40. Wang P, Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, Madri JA, Fikrig E: Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 2008;82:8978-8985.
41. Hartung HP, Kieseier BC: The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 2000;107:140-147.
42. Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494. (Pubitemid 129519680)
43. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839. (Pubitemid 36542523)
44. Glass WG, Chen BP, Liu MT, Lane TE: Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol 2002;15:261-272. (Pubitemid 34651530)
45. Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA: Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 1997;233:260-270. (Pubitemid 27314813)
46. Rempel JD, Murray SJ, Meisner J, Buchmeier MJ: Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 2004;318:381-392. (Pubitemid 38234289)
47. Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A: Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon therapy in relapsing and secondary progressive multiple sclerosis patients. Ann Neurol 2001;50:443-451. (Pubitemid 32938887)
48. Ethell IM, Ethell DW: Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 2007;85:2813-2823. (Pubitemid 47523564)
49. Chaturvedi UC, Mathur A, Tandon P, Natu SM, Rajvanshi S, Tandon HO: Variable effect on peripheral blood leucocytes during JE virus infection of man. Clin Exp Immunol 1979;38:492-498. (Pubitemid 10159435)
50. Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W: Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 1985;18:567-573. (Pubitemid 16258092)
51. Mathur A, Khanna N, Chaturvedi UC: Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int J Exp Pathol 1992;73: 603-611.
52. Leppert D, Lindberg RL, Kappos L, Leib SL: Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001;36:249-257. (Pubitemid 33020755)
53. Özenci V, Rinaldi L, Teleshova N, Matusevicius D, Kivisäkk P, Kouwenhoven M, Link H: Metalloproteinases and their tissue inhibitors in multiple sclerosis. J Autoimmun 1999;12:297-303. (Pubitemid 29261966)
54. Waubant E, Goodkin DE, Gee L, Bacchetti P, Sloan R, Stewart T, Andersson PB, Stabler G, Miller K: Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999;53:1397-1401. (Pubitemid 29491927)
55. Zhou J, Stohlman SA, Hinton DR, Marten NW: Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 2003;170:3331-3336. (Pubitemid 36302212)
56. Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia 2002;39:279-291.
57. Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, Sen E, Basu A: Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 2007;55:483-496. (Pubitemid 46383178)
58. Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin MF, Akaoka H: T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J Immunol 2000;164:2718-2727. (Pubitemid 30115505)
59. Giraudon P, Thomasset N, Bernard A, Verrier B, Belin MF: Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase 2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur J Neurosci 1995;7:841-848.
60. Maeda A, Sobel RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55:300-309. (Pubitemid 26085579)
61. Cossins JA, Clements JM, Ford J, Miller KM, Pigott R, Vos W, Van Der Valk P, De Groot CJ: Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997;94:590-598. (Pubitemid 27511181)
62. Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P: Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol 2000;6:156-163. (Pubitemid 30303574)
63. Leib SL, Leppert D, Clements J, Tauber MG: Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000;68:615-620. (Pubitemid 30056514)
64. Tung WH, Tsai HW, Lee I: Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-κB signalling dependent on MAPKs and reactive oxygen species. Br J Pharmacol 2010;161:1566-1583.
65. Mishra MK, Ghosh D, Duseja R, Basu A: Antioxidant potential of minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int 2009;54:464-470.
66. Opdenakker G, Van den Steen PE, Van Damme J: Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-579. (Pubitemid 33016405)
67. Huang TY, Chu HC, Lin YL, Lin CK, Hsieh TY, Chang WK, Chao YC, Liao CL: Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol Appl Pharmacol 2009;237:69-82.
68. Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC: Minocycline for short-term neuroprotection. Pharmacotherapy 2006;26:515-521.
69. Dutta K, Mishra MK, Nazmi A, Kumawat KL, Basu A: Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection. Immunobiology 2010;215:884-893.